(RTTNews) - Private sector employment in the U.S. jumped by more than expected in the month of September, according to a report released by payroll processor ADP on Wednesday.
(RTTNews) - Mattel, Inc. (MAT), a toy maker and entertainment company, said on Wednesday that its Chairman and Chief Executive Officer, Ynon Kreiz, will step down with effect from October 2 to take up a senior leadership role at another company.
(RTTNews) - Jade Biosciences, Inc. (JBIO) announced preclinical data for JADE301, an investigational, anti-IFN-Beta monoclonal antibody being developed for dermatomyositis, a rare autoimmune disease that can cause skin inflammation and muscle weakness.
(RTTNews) - Immunome, Inc. (IMNM), a clinical-stage targeted oncology company, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for IM-1340, a potential first-in-class antibody-drug conjugate (ADC) for treating
(RTTNews) - Rafael Holdings (RFL) reported topline results from the pivotal Phase 3 TransportNPC study evaluating Trappsol Cyclo in patients with Niemann-Pick Disease Type C (NPC).
(RTTNews) - A liver-focused RNA medicine candidate from Wave Life Sciences (WVE) is moving into GSK's development pipeline, triggering a $12 million milestone payment to Wave under their research collaboration.
(RTTNews) - European stocks pared early gains and slipped into negative territory on Wednesday as oil prices rebounded amid continued uncertainty about U.S. and Iran reaching a deal to end their conflict anytime soon.
(RTTNews) - On Wednesday, Tiziana Life Sciences (TLSA) said it submitted a request to the U.S. Food and Drug Administration (FDA) for Orphan Drug Designation for intranasal foralumab for the treatment of Multiple System Atrophy (MSA).
(RTTNews) - General Mills, Inc. (GIS), a maker of branded consumer foods, said on Wednesday that it has appointed its Chief Operating Officer, Dana McNabb, as chief executive officer to succeed Jeff Harmening.
Allstate Corp (Symbol: ALL) has been named as a Top 10 dividend-paying financial stock, according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among shares of financial companies, ALL displayed both attractive valuation me
(RTTNews) - Sagimet Biosciences Inc. (SGMT), announced on Wednesday that it has priced an underwritten offering of 8.75 million shares of Series A common stock at $10 each, raising about $115 million.
(RTTNews) - On Wednesday, Connect Biopharma Holdings Limited (CNTB) reported positive preliminary topline results from its global Phase 2 Seabreeze STAT COPD study evaluating rademikibart as an add-on treatment for acute exacerbations in adults with COPD and type 2 inflammation.
(RTTNews) - Wednesday, Rafael Holdings (RFL) reported topline results from the pivotal Phase 3 TransportNPC study evaluating Trappsol Cyclo in patients with Niemann-Pick Disease Type C (NPC).
The S&P 500 Index ($SPX ) (SPY ) closed down by -0.17% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.21%. December E-mini S&P futures (ESZ26 ) fell -0.15%, and December E-mini...